These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 25951659

  • 1. Dissolution enhancement of gliclazide using ultrasound waves and stabilizers in liquid anti-solvent precipitation.
    Al-Nimry SS, Qandil AM, Salem MS.
    Pharmazie; 2014 Dec; 69(12):874-80. PubMed ID: 25951659
    [Abstract] [Full Text] [Related]

  • 2. Dissolution rate enhancement of gliclazide by ordered mixing.
    Saharan VA, Choudhury PK.
    Acta Pharm; 2011 Sep 01; 61(3):323-34. PubMed ID: 21945911
    [Abstract] [Full Text] [Related]

  • 3. Dissolution enhancement of gliclazide using pH change approach in presence of twelve stabilizers with various physico-chemical properties.
    Talari R, Varshosaz J, Mostafavi SA, Nokhodchi A.
    J Pharm Pharm Sci; 2009 Sep 01; 12(3):250-65. PubMed ID: 20067702
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Micronization of atorvastatin calcium by antisolvent precipitation process.
    Zhang HX, Wang JX, Zhang ZB, Le Y, Shen ZG, Chen JF.
    Int J Pharm; 2009 Jun 05; 374(1-2):106-13. PubMed ID: 19446766
    [Abstract] [Full Text] [Related]

  • 8. In vitro evaluation and in vivo performance of lyophilized gliclazide.
    Mansour HF, Aly UF.
    Drug Dev Ind Pharm; 2015 Apr 05; 41(4):650-7. PubMed ID: 24568609
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E, Cho W, Cha KH, Park J, Kim MS, Kim JS, Park HJ, Hwang SJ.
    Int J Pharm; 2010 Aug 30; 396(1-2):91-8. PubMed ID: 20558265
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes.
    Aggarwal S, Singh PN, Mishra B.
    Pharmazie; 2002 Mar 30; 57(3):191-3. PubMed ID: 11933849
    [Abstract] [Full Text] [Related]

  • 15. Gastrointestinal transition and anti-diabetic effect of Isabgol husk microparticles containing gliclazide.
    Sharma VK, Mazumder B.
    Int J Biol Macromol; 2014 May 30; 66():15-25. PubMed ID: 24530641
    [Abstract] [Full Text] [Related]

  • 16. Multicomponent crystals of gliclazide and tromethamine: preparation, physico-chemical, and pharmaceutical characterization.
    Bruni G, Berbenni V, Maggi L, Mustarelli P, Friuli V, Ferrara C, Pardi F, Castagna F, Girella A, Milanese C, Marini A.
    Drug Dev Ind Pharm; 2018 Feb 30; 44(2):243-250. PubMed ID: 28956461
    [Abstract] [Full Text] [Related]

  • 17. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubert RH, Hwang SJ.
    Eur J Pharm Biopharm; 2008 Jun 30; 69(2):454-65. PubMed ID: 18359211
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.